Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

504 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study.
Joly P, Roujeau JC, Benichou J, Delaporte E, D'Incan M, Dreno B, Bedane C, Sparsa A, Gorin I, Picard C, Tancrede-Bohin E, Sassolas B, Lok C, Guillaume JC, Doutre MS, Richard MA, Caux F, Prost C, Plantin P, Chosidow O, Pauwels C, Maillard H, Saiag P, Descamps V, Chevrant-Breton J, Dereure O, Hellot MF, Esteve E, Bernard P. Joly P, et al. Among authors: roujeau jc. J Invest Dermatol. 2009 Jul;129(7):1681-7. doi: 10.1038/jid.2008.412. Epub 2009 Jan 29. J Invest Dermatol. 2009. PMID: 19177141 Free article. Clinical Trial.
Treatment of bullous pemphigoid.
Fontaine J, Joly P, Roujeau JC. Fontaine J, et al. Among authors: roujeau jc. J Dermatol. 2003 Feb;30(2):83-90. doi: 10.1111/j.1346-8138.2003.tb00353.x. J Dermatol. 2003. PMID: 12692373 Review.
Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicenter, prospective, cohort study.
Bernard P, Reguiai Z, Tancrède-Bohin E, Cordel N, Plantin P, Pauwels C, Vaillant L, Grange F, Richard-Lallemand MA, Sassolas B, Roujeau JC, Lok C, Picard-Dahan C, Chosidow O, Vitry F, Joly P. Bernard P, et al. Among authors: roujeau jc. Arch Dermatol. 2009 May;145(5):537-42. doi: 10.1001/archdermatol.2009.53. Arch Dermatol. 2009. PMID: 19451497
Risk factors for bullous pemphigoid in the elderly: a prospective case-control study.
Bastuji-Garin S, Joly P, Lemordant P, Sparsa A, Bedane C, Delaporte E, Roujeau JC, Bernard P, Guillaume JC, Ingen-Housz-Oro S, Maillard H, Pauwels C, Picard-Dahan C, Dutronc Y, Richard MA; French Study Group for Bullous Diseases. Bastuji-Garin S, et al. Among authors: roujeau jc. J Invest Dermatol. 2011 Mar;131(3):637-43. doi: 10.1038/jid.2010.301. Epub 2010 Oct 14. J Invest Dermatol. 2011. PMID: 20944650 Free article.
Drugs associated with bullous pemphigoid. A case-control study.
Bastuji-Garin S, Joly P, Picard-Dahan C, Bernard P, Vaillant L, Pauwels C, Salagnac V, Lok C, Roujeau JC. Bastuji-Garin S, et al. Among authors: roujeau jc. Arch Dermatol. 1996 Mar;132(3):272-6. Arch Dermatol. 1996. PMID: 8607630 Clinical Trial.
Neurological disorders in patients with bullous pemphigoid.
Cordel N, Chosidow O, Hellot MF, Delaporte E, Lok C, Vaillant L, Bernard P, D'Incan M, Roujeau JC, Joly P; French Study Group of Bullous Diseases. Cordel N, et al. Among authors: roujeau jc. Dermatology. 2007;215(3):187-91. doi: 10.1159/000106574. Dermatology. 2007. PMID: 17823513
Prediction of survival for patients with bullous pemphigoid: a prospective study.
Joly P, Benichou J, Lok C, Hellot MF, Saiag P, Tancrede-Bohin E, Sassolas B, Labeille B, Doutre MS, Gorin I, Pauwels C, Chosidow O, Caux F, Estève E, Dutronc Y, Sigal M, Prost C, Maillard H, Guillaume JC, Roujeau JC. Joly P, et al. Among authors: roujeau jc. Arch Dermatol. 2005 Jun;141(6):691-8. doi: 10.1001/archderm.141.6.691. Arch Dermatol. 2005. PMID: 15967914 Clinical Trial.
504 results